Literature DB >> 1757533

Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens.

J A Kluytmans1, H G Niesters, J W Mouton, W G Quint, J A Ijpelaar, J H Van Rijsoort-Vos, L Habbema, E Stolz, M F Michel, J H Wagenvoort.   

Abstract

The Gen-Probe PACE 2 assay (GP), a nonisotopic DNA probe, was evaluated by using cell culture as the method of reference. Specimens were collected from 260 men and 482 women visiting the outpatient department for sexually transmitted diseases at the University Hospital in Rotterdam, The Netherlands. The prevalences of Chlamydia culture-positive men and women were 13.2 and 8.6%, respectively. Sensitivity values for the male and female patients were 70.6 and 92.7%, respectively. Specificity values for these groups were 98.2 and 97.7%, respectively. Sensitivity was significantly lower when the number of inclusions in cell culture was low. Samples which showed a discordance between cell culture and GP results were retested by the polymerase chain reaction. If the results of the polymerase chain reaction were considered as the points of reference, the sensitivity and specificity of both GP and cell culture could be calculated. The performance of GP for females was comparable to that of cell culture. In males, the sensitivity of GP was considerably lower than that of cell culture (77.2 versus 91.4%), while specificity was somewhat higher (99.6 versus 99.1%). Compared with cell culture, the GP is a relatively simple and rapid test that is suitable for diagnosing Chlamydia infections in urogenital specimens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757533      PMCID: PMC270414          DOI: 10.1128/jcm.29.12.2685-2689.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction.

Authors:  H C Claas; W J Melchers; I H de Bruijn; M de Graaf; W C van Dijk; J Lindeman; W G Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

2.  Comparison of DNA probe, monoclonal antibody enzyme immunoassay, and cell culture for the detection of Chlamydia trachomatis.

Authors:  W LeBar; B Herschman; C Jemal; J Pierzchala
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

3.  Comparison of chemiluminescent DNA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic population.

Authors:  L J Mercer; D C Robinson; D F Sahm; M J Lawrie; S N Hajj
Journal:  Obstet Gynecol       Date:  1990-07       Impact factor: 7.661

Review 4.  Genital Chlamydia infections.

Authors:  J M Ehret; F N Judson
Journal:  Clin Lab Med       Date:  1989-09       Impact factor: 1.935

5.  Eubacterial origin of chlamydiae.

Authors:  W G Weisburg; T P Hatch; C R Woese
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

6.  Enhancement of yield of Chlamydia trachomatis Hela 229 cell culture.

Authors:  J T Wagenvoort; T van Rijsoort-Vos; A Overkleeft-van de Ree; E Stolz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

7.  Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay.

Authors:  L Bobo; F Coutlee; R H Yolken; T Quinn; R P Viscidi
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

8.  Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J A Kluytmans; A H van der Willigen; B Y van Heyst; W I van der Meyden; E Stolz; J H Wagenvoort
Journal:  Int J STD AIDS       Date:  1990-01       Impact factor: 1.359

9.  Comparison of the Gen-Probe PACE 2 system, direct fluorescent-antibody, and cell culture for detecting Chlamydia trachomatis in cervical specimens.

Authors:  P C Iwen; T M Blair; G L Woods
Journal:  Am J Clin Pathol       Date:  1991-04       Impact factor: 2.493

Review 10.  Laboratory diagnosis of human chlamydial infections.

Authors:  R C Barnes
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

View more
  24 in total

1.  Evaluation of an in-house polymerase chain reaction for detection of Neisseria gonorrhoeae in urogenital samples.

Authors:  R Roymans; G Onland; A Jansz; W Quint; E Boel
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

2.  Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men.

Authors:  J B Mahony; K E Luinstra; J W Sellors; D Jang; M A Chernesky
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Rapid screening and treatment for sexually transmitted diseases in arrestees: a feasible control measure.

Authors:  J F Beltrami; D A Cohen; J T Hamrick; T A Farley
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

4.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Use of gen-probe probe competition assay as a supplement to probes for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital specimens.

Authors:  G L Woods; D M Garza
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women.

Authors:  K A Crotchfelt; B Pare; C Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

7.  Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory.

Authors:  R J Limberger; R Biega; A Evancoe; L McCarthy; L Slivienski; M Kirkwood
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

8.  Evaluation of the Amplicor Chlamydia trachomatis test versus culture in genital samples in various prevalence populations.

Authors:  B de Barbeyrac; I Pellet; B Dutilh; C Bébéar; B Dumon; M Géniaux; C Bébéar
Journal:  Genitourin Med       Date:  1994-06

9.  Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J A Kluytmans; W H Goessens; J W Mouton; J H van Rijsoort-Vos; H G Niesters; W G Quint; L Habbema; E Stolz; J H Wagenvoort
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population.

Authors:  L M Clarke; M F Sierra; B J Daidone; N Lopez; J M Covino; W M McCormack
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.